TSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/24/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSE
Market Capitalization7,644.15 mln
Float234 mln
Earnings Date08/18/2025
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-4.77
Highly reliable
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.05
Debt-free
ROE
-41.77
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Solasia Pharma K.K. is a pharmaceutical company founded in 2006 and based in Minato, Japan, that sells and distributes medicines and medical devices across Japan, China, South Korea, and other markets. Its current lineup includes treatments for mouth sores caused by cancer therapy, a drug for a rare type of blood cancer, and a patch that helps patients manage nausea during chemotherapy. The company is also working on two early-stage treatments aimed at nerve damage and colorectal cancer caused by chemotherapy.
